News | Medical 3-D Printing | December 11, 2023

Mentice Enters Agreement to Acquire All Substantial Assets from Biomodex

Mentice AB, a world leader in simulation solutions for image guided interventional therapies, announced today that it has entered into an agreement to acquire all substantial assets from Paris-based company Biomodex

Getty Images


December 11, 2023 — Mentice AB, a world leader in simulation solutions for image guided interventional therapies, announced today that it has entered into an agreement to acquire all substantial assets from Paris-based company Biomodex for a purchase price of 200,000 EUR, following a decision by their board to dissolve operations. The global Biomodex business reached a total turnover of 2.2 million EUR in 2022.

The Acquisition

Biomodex specializes in biorealistic 3D printing and flow systems for interventional procedures, with a platform geared towards clinical use and patient-specific simulation. As part of the acquisition, Mentice will also retain key employees of Biomodex. “Biomodex is truly a quality product company, with experienced staff and a large and highly engaged customer base which is a testament to the value they bring to the market”, said Edward Fält, Chief Strategy Officer of Mentice. “Since its inception in 2015, Biomodex has invested over 12 million EUR in IP and R&D, leading to the development of several innovative products and technology advances which will be very synergistic to Mentice’s current portfolio. Thanks to a series of circumstances, we were able to acquire these assets under favorable terms and are now looking forward to taking the business to the next level under the umbrella of the global Mentice organization.”

The acquisition will further consolidate Mentice’s position as the leading provider of virtual, physical and decision-support simulation solutions for image-guided interventional therapies. The acquired assets will add new solutions for neurovascular and structural heart simulation as well as a rapid turn-around production process for direct printing of patient-specific anatomies.

Over the course of 2024, Mentice aims to focus on integrating the Biomodex staff, product lines and production into its existing business areas.

As an immediate step, Mentice will be reaching out to all Biomodex customers with more information on the combined offering and how to request product and sales support.

For more information: www.mentice.com


Related Content

News | Cardiovascular Business

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership ...

Home May 22, 2024
Home
News | Cardiovascular Business

May 14, 2024 — GE HealthCare, a leading global medical technology, pharmaceutical diagnostics and digital solutions ...

Home May 14, 2024
Home
News | Cardiovascular Business

May 6, 2024 — SMT (Sahajanand Medical Technologies), a leading medical device company at the forefront of innovative ...

Home May 06, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Clinical trials and innovative technology took center stage during the month of April, racking up some record number ...

Home May 03, 2024
Home
News | Cardiovascular Business

April 29, 2024 — Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure ...

Home April 29, 2024
Home
News | Cardiovascular Business

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

Home April 09, 2024
Home
News | Cardiovascular Business

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

Home April 05, 2024
Home
News | Cardiovascular Business

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com: 1. CLS Health ...

Home April 04, 2024
Home
News | Cardiovascular Business

March 19, 2024 — The American College of Cardiology (ACC) has selected 50 learners for its 2024 – 2025 Clinical Trials ...

Home March 19, 2024
Home
Subscribe Now